The cuts at BMS just keep on cutting.
https://www.fiercebiotech.com/biotech/bristol-myers-backs-out-dupixent-fight-axing-allergy-asset-despite-phase-3-win

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service